Abstract As the pharmaceutical landscape becomes increasingly complex in 2026, global signal detection is emerging as a critical component of drug safety. Advanced therapies, biologics, and personalized medicine require proactive monitoring strategies that go beyond traditional approaches. This review examines the key trends shaping pharmacovigilance, including artificial intelligence, real-world evidence, predictive analytics, and global collaboration....